Evaluation of a Zika virus-like particle-based vaccine in a highly penetrant non-human primate model of congenital infection
PLOS Neglected Tropical Diseases · 2026
DOI: 10.1371/journal.pntd.0014692 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Neglected Tropical Diseases, 2026. Verfasst von Hannah K Jaeger und 29 weiteren Autor:innen. Beteiligte Einrichtung: The Vaccine & Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America. Hauptthemen laut MEDLINE: Zika Virus Infection, Zika Virus, Vaccines, Virus-Like Particle, Viral Vaccines. Die Arbeit nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NICHD NIH HHS, National Institute of Child Health and Human Development.
Abstract (Originalsprache)
Zika virus (ZIKV) is an arthropod-borne Orthoflavivirus that caused a major outbreak in Central and South America in 2015–16. During that outbreak, ZIKV infection during pregnancy was associated with high rates of adverse outcomes, including miscarriage and a spectrum of neurological birth defects collectively termed congenital Zika syndrome (CZS). Ten years later, there are still no licensed ZIKV vaccines, underscoring the need for robust experimental models to evaluate vaccine efficacy against congenital disease. Here, we evaluated a highly pathogenic nonhuman primate pregnancy model for its ability to assess vaccine-mediated protection using a Zika virus-like particle (VLP) vaccine as a test platform. First, non-pregnant rhesus macaques (RM) were vaccinated with a prime-boost method to compare control, VLP alone, and VLP plus Alhydrogel (alum) adjuvant. Vaccination plus alum elicited strong neutralizing antibody responses and reduced viral dissemination compared to controls. Next, we evaluated the vaccine’s protective efficacy against adverse pregnancy complications. Two cohorts of female RM were vaccinated with ZIKV-VLP adjuvanted with alum or alum alone prior to time-mated breeding. At gestational day (GD) 30 (mid first trimester), pregnant animals were challenged with ZIKV-DAK 41524, an African-lineage strain previously shown to induce frequent first-trimester pregnancy loss. Within the vaccinated cohort, two of three animals reached the study endpoint of GD 90 with no observed adverse pregnancy outcomes. One vaccinated animal experienced early pregnancy loss despite the absence of detectable virus in fetal or placental tissues. In the sham vaccine control pregnancy cohort, severe adverse outcomes included miscarriage and hydrops fetalis with widespread viral RNA and placental pathology in two animals. These results support a high risk of early pregnancy loss following African-lineage ZIKV-DAK 41524 infection in RM. This model can be further used to understand the complexities of placental immunological features underlying miscarriage following ZIKV infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- The Vaccine & Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
- Division of Pathobiology & Immunology, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.
- Division of Reproductive & Developmental Sciences, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.
- Department of Obstetrics & Gynecology, Oregon Health & Science University, Portland, Oregon, United States of America.
- Department of Veterinary and Biomedical Sciences, University of Minnesota, St. Paul, Minnesota, United States of America.
- Department of Pathobiological Sciences, School of Veterinary Medicine and Wisconsin National Primate Research Center, University of Wisconsin-Madison, Madison, Wisconsin, United States of America.
ORCID-Profile: Alec J Hirsch
Förderung
- NIH HHS
- NICHD NIH HHS
- National Institute of Child Health and Human Development
- National Institutes of Health
Zitieren
APA
Jaeger, H. K., Smith, J. L., Labriola, C. S., Pung, L. J., Hagen, O. L., Denton, M., D'Mello, R. J., Parkins, C. J., Weber, W. C., Medica, S., Kreklywich, C. N., DeFilippis, V. R., Bondoc, S., Busman-Sahay, K., Castro, J. N., Zilverberg, G., White, R., Terry, M., Barber-Axthelm, A. M., …, & Hirsch, A. J. (2026). Evaluation of a Zika virus-like particle-based vaccine in a highly penetrant non-human primate model of congenital infection. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0014692
Vancouver
Jaeger HK, Smith JL, Labriola CS, Pung LJ, Hagen OL, Denton M, et al. Evaluation of a Zika virus-like particle-based vaccine in a highly penetrant non-human primate model of congenital infection. PLOS Neglected Tropical Diseases. 2026. doi:10.1371/journal.pntd.0014692
BibTeX
@article{Jaeger2026,
author = {Jaeger, Hannah K and Smith, Jessica L and Labriola, Caralyn S and Pung, Lydia J and Hagen, Olivia L and Denton, Michael and D'Mello, Rahul J and Parkins, Christopher J and Weber, Whitney C and Medica, Samuel and Kreklywich, Craig N and DeFilippis, Victor R and Bondoc, Stephen and Busman-Sahay, Kathleen and Castro, Jenna N and Zilverberg, Gavin and White, Riely and Terry, Margaret and Barber-Axthelm, Aaron M and Axthelm, Michael K and Smedley, Jeremy and Aliota, Matthew T and Weiler, Andrea M and Friedrich, Thomas C and Estes, Jacob and Morgan, Terry K and Lo, Jamie O and Roberts, Victoria H J and Streblow, Daniel N and Hirsch, Alec J},
title = {Evaluation of a Zika virus-like particle-based vaccine in a highly penetrant non-human primate model of congenital infection},
journal = {PLOS Neglected Tropical Diseases},
year = {2026},
doi = {10.1371/journal.pntd.0014692}
}
EUVIMED